<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="mig01/PMC7193175/results/search/migration/results.xml">
  <result pre="Research Articles LncRNA EGOT decreases breast cancer cell viability and" exact="migration" post="via inactivation of the Hedgehog pathway Role of EGOT"/>
  <result pre="Transcript (EGOT) has been reported to inhibit the proliferation and" exact="migration" post="of glioma cells, and promote the development and progression"/>
  <result pre="purmorphamine, an agonist of the Hh pathway. Cell viability and" exact="migration" post="were also restored by purmorphamine. We conclude that lncRNA"/>
  <result pre="that lncRNA EGOT may inhibit breast cancer cell viability and" exact="migration" post="via inactivation of the Hh pathway. Long noncoding RNA"/>
  <result pre="pathway genes and reversed the effects on cell viability and" exact="migration" post="caused by overexpression of EGOT. EGOT thus may inhibit"/>
  <result pre="EGOT. EGOT thus may inhibit breast cancer cell viability and" exact="migration" post="via inhibition of the Hh pathway. breast cancer cell"/>
  <result pre="migration via inhibition of the Hh pathway. breast cancer cell" exact="migration" post="cell proliferation Hedgehog pathway lncRNA EGOT Funding Joint Program"/>
  <result pre="al. [11] have found that EGOT inhibits the proliferation and" exact="migration" post="of glioma cells and promotes apoptosis in human gliomas."/>
  <result pre="abnormal expressions in lncRNA EGOT, along with the viability and" exact="migration" post="of breast cancer cell lines and the Hh signaling"/>
  <result pre="versus HEK293 cells. Overexpression of EGOT impedes cell proliferation and" exact="migration" post="The expression of EGOT from BT549 was the lowest"/>
  <result pre="in the pcDNA–EGOT group compared with pcDNA (Fig. 2B). Cell" exact="migration" post="was then detected using a Transwell migration and wound"/>
  <result pre="(Fig. 2B). Cell migration was then detected using a Transwell" exact="migration" post="and wound healing assay, with results revealing that the"/>
  <result pre="migration and wound healing assay, with results revealing that the" exact="migration" post="ability of cells transfected with pcDNA–EGOT was tremendously impaired"/>
  <result pre="assess cell viability. (C, D) Wound healing assays and Transwell" exact="migration" post="assays were used to detect cell migration after an"/>
  <result pre="assays and Transwell migration assays were used to detect cell" exact="migration" post="after an overexpression of EGOT. Scale bars: 200 μm"/>
  <result pre="***P &amp;lt; 0.001. NS, not significant. Purmorphamine restores viability and" exact="migration" post="in breast cancer cell line BT549, with an overexpression"/>
  <result pre="treated with purmorphamine. Moreover, the results of cell viability and" exact="migration" post="showed a similar tendency to the cell viability during"/>
  <result pre="5 Effect of Hh signaling pathway on cell viability and" exact="migration" post="in breast cancer cell line BT549. BT549 cells were"/>
  <result pre="(B) and Transwell assays (C) were used to detect cell" exact="migration" post="in these groups. Scale bars: 200 μm (B); 100"/>
  <result pre="As expected, overexpression in EGOT negatively affected cell proliferation and" exact="migration" post="(Fig. 2). Therefore, the role of EGOT in breast"/>
  <result pre="[40]. Purmorphamine was then used to measure cell proliferation and" exact="migration" post="ability in the overexpression system of EGOT. Results indicated"/>
  <result pre="of EGOT. Results indicated that purmorphamine reversed cell proliferation and" exact="migration" post="abilities in breast cancer (Fig. 5). According to the"/>
  <result pre="we inferred, the overexpression of EGOT impaired cell viability and" exact="migration" post="in BT549 cell lines. Furthermore, the expression of Gli1"/>
  <result pre="of PTCH1, SMO, Gli1 and HHIP, and cell viability and" exact="migration" post="caused by an overexpression of EGOT were reversed by"/>
  <result pre="lncRNA EGOT is proved to inhibit TNBC cell viability and" exact="migration" post="via modulation of the Hh pathway. Our present research"/>
  <result pre="methods for TNBC. Conflict of interest The authors declare no" exact="conflict" post="of interest. Author contributions SQ and GBC conducted experiments"/>
  <result pre="noncoding RNA eosinophil granule ontogeny transcript inhibits cell proliferation and" exact="migration" post="and promotes cell apoptosis in human glioma. Exp Ther"/>
  <result pre="237–245.21516412 22JustusCR, LefflerN, Ruiz‐EchevarriaM and YangLV (2014) In vitro cell" exact="migration" post="and invasion assays. J Vis Exp88, e51046. 23RodriguezLG, WuX"/>
 </snippets>
</snippetsTree>
